AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 268 filers reported holding AVANOS MED INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,177 | +176.5% | 27,803 | +249.5% | 0.00% | 0.0% |
| Q2 2023 | $203,304 | -1.6% | 7,954 | +14.5% | 0.00% | 0.0% |
| Q1 2023 | $206,574 | -60.1% | 6,946 | -70.8% | 0.00% | -66.7% |
| Q3 2022 | $518,000 | -45.0% | 23,805 | -8.0% | 0.00% | -25.0% |
| Q2 2021 | $941,000 | +40.7% | 25,876 | +69.1% | 0.00% | 0.0% |
| Q1 2021 | $669,000 | -3.5% | 15,305 | -26.6% | 0.00% | -55.6% |
| Q3 2020 | $693,000 | +30.0% | 20,858 | +15.1% | 0.01% | 0.0% |
| Q2 2020 | $533,000 | +129.7% | 18,124 | +163.6% | 0.01% | +800.0% |
| Q4 2019 | $232,000 | -32.0% | 6,876 | -12.1% | 0.00% | -66.7% |
| Q2 2019 | $341,000 | -83.8% | 7,821 | -83.4% | 0.00% | -88.0% |
| Q4 2018 | $2,107,000 | +69.1% | 47,037 | +158.6% | 0.02% | +66.7% |
| Q3 2018 | $1,246,000 | – | 18,187 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |